~14 spots leftby May 2025

Diabetes BOOST Program for Type 2 Diabetes

Recruiting in Palo Alto (17 mi)
+1 other location
Overseen byDaniel Amante, PhD, MPH
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Daniel Amante
Disqualifiers: Cognitive impairment, Pregnant, others
No Placebo Group

Trial Summary

What is the purpose of this trial?The specific aims of this project are to culturally adapt the DM-BOOST intervention for Latinx patients, usability test 'DM-BOOST para Latinx' to optimize cultural appropriateness and patient engagement and conduct a feasibility evaluation of DM-BOOST para Latinx. These aims will be accomplished via a community-based participatory research approach in collaboration with clinical, community and patient partners. This project will inform subsequent proposals to evaluate implementation of DM-BOOST in the UMass Memorial Health Care system.

Eligibility Criteria

This trial is for Hispanic/Latinx adults over 18 with type 2 diabetes who prefer to speak Spanish and have completed a diabetes self-management training in the past year. It's not suitable for those with cognitive impairments, pregnant women, or current prisoners.

Inclusion Criteria

I am older than 18 years.
I have been diagnosed with type 2 diabetes.
I completed a diabetes self-management training last year.
+2 more

Exclusion Criteria

Pregnant women
Current prisoner
I have difficulty with memory or thinking clearly.

Trial Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants complete a baseline survey, receive DSMT referral, and engage in self-care education via secure messages, text messages, and video calls. They also complete a telehealth training video call and set personalized goals.

3 months
Multiple virtual interactions

Follow-up

Participants complete a 3-month follow-up survey and qualitative interview to assess diabetes treatment satisfaction and self-efficacy.

3 months

Extended Follow-up

Participants' HbA1c values are monitored to determine the impact of the intervention, with data obtained through EHR chart review.

6 months

Participant Groups

The study is testing 'DM-BOOST para Latinx,' an adapted version of the DM-BOOST program designed to help Latinx patients manage their diabetes using behavioral economics and technology. The effectiveness will be assessed through community-based participatory research.
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - Diabetes BOOSTExperimental Treatment1 Intervention
Intervention group participants will complete a baseline survey, receive a referral to DSMT from the research team, a mailed welcome letter and self-care education sent via a series of personalized patient portal secure messages, text messages, and video call. They will be sent text messages with information about one of the American Association of Diabetes Educators 7 self-care behaviors and will receive encouragement to author their own self-management behavioral goals. Participants will also complete a telehealth training video call with research staff to review the functionality of their patient portal and refine diabetes-related goals. The participant will then be encouraged to send a patient portal message to their DSMT CDCES that includes their personalized goals prior to their scheduled DSMT session. They will then complete a 3-month follow-up survey and qualitative interview.
Group II: Usual CareActive Control1 Intervention
Comparison Group participants will complete a baseline survey, receive a DSMT referral request from research team to their primary care provider and a mailed welcome letter. The mailed letter will welcome the participant to the study and contain general information about diabetes self-care behaviors and goal setting. They will complete a DSMT session. They will then complete a 3-month follow-up survey and qualitative interview.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
UMass Memorial healthWorcester, MA
University of Massachusetts Medical SchoolWorcester, MA
Loading ...

Who Is Running the Clinical Trial?

Daniel AmanteLead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Collaborator

References